| Aug 14 |
Tiziana Life Sciences regains compliance with Nasdaq
|
| Aug 14 |
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
|
| Jul 24 |
Tiziana spikes on FDA fast track tag for lead asset
|
| Jul 24 |
Tiziana Life Sciences Granted FDA Fast Track Designation
|
| Jun 28 |
Tiziana announces $3.4M non-dilutive funding
|
| Jun 28 |
Tiziana Receives $3.4 Million in Non-Dilutive Funding
|
| Jun 26 |
Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab
|
| Jun 11 |
Tiziana multiple sclerosis asset foralumab Fast Track application accepted
|
| Jun 11 |
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis
|
| Jun 6 |
Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
|
